Zobrazeno 1 - 10
of 74
pro vyhledávání: '"N. F. Orel"'
Autor:
I. V. Poddubnaya, D. A. Sychev, G. R. Abuzarova, A. K. Allakhverdiev, P. P. Arkhiri, L. G. Babicheva, M. P. Baranova, M. I. Volkova, A. V. Ignatova, A. Iu. Kashurnikov, R. I. Kniazev, I. V. Kolyadina, I. G. Komarov, A. V. Kriukov, N. V. Levitskaia, V. K. Liadov, O. A. Malikhova, S. N. Nered, N. F. Orel, S. O. Podviaznikov, I. V. Sagaidak, R. R. Sarmanaeva, I. S. Stilidi, O. P. Trofimova, G. S. Tumian, T. V. Kharitonova
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 56-73 (2020)
The training module was developed by the staff of the department under the leadership of the head. Department of Academician of RAS, Professor I.V. Poddubnoy and Rector of FSBEI DPO RMANPO of the Ministry of Health of Russia, Corr. RAS, Professor D.A
Externí odkaz:
https://doaj.org/article/828b754feb9b44bfa87fb7395a012d1c
Autor:
A. A. Markovich, A. A. Kuznetsova, V. A. Gorbunova, N. F. Orel, A. S. Odintsova, G. S. Emelyanova, A. E. Kuzminov
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 115-119 (2019)
The treatment efficacy and toxicity profile was evaluated in 33 patients with highly differentiated neuroendocrine tumors NEO (G1, G2), who received sunitinib therapy in various dose regimens. Stable disease was achieved in 24 patients (72.7%), parti
Externí odkaz:
https://doaj.org/article/29b703d41c8746dbadeff556b5ccdea9
Autor:
A. A. Kolomeytseva, V. V. Delektorskaya, N. F. Orel, G. S. Emelianova, V. Y. Bokhian, A. A. Fedenko
Publikováno v:
Сибирский онкологический журнал, Vol 17, Iss 2, Pp 111-117 (2018)
Background. Adrenocortical cancer (ACC) is a rare malignancy of the adrenal cortex. Therapeutic options for advanced ACC are limited. It is necessary to study new and more effective drug combinations and tumor biological targets. The purpose of the s
Externí odkaz:
https://doaj.org/article/9cd05afd8cae4ce5990e78a8d968b3f4
Autor:
G. S. Emelianova, N. F. Orel, V. A. Gorbunova, A. A. Kolomeytseva, A. A. Kuznetsova, A. E. Kuzminov, A. A. Fedenko
Publikováno v:
Сибирский онкологический журнал, Vol 16, Iss 6, Pp 100-104 (2017)
Advanced well differentiated neuroendocrine tumors (NET) have poor sensitivity to chemotherapy. Biotherapy and targeted therapy are the main treatment options for these patients. Approaches to the 2nd and subsequent lines of treatment have not been d
Externí odkaz:
https://doaj.org/article/c0f77ee0f2584480bb4c96f6dbc1ffcb
Autor:
T. D. Tabolinovskaya, A. M. Mudunov, S. B. Alieva, N. F. Orel, L. E. Komarova, E. R. Oganyan, I. N. Pustynskiy, R. A. Khasanov, T. A. Aketova, N. A. Pirogova
Publikováno v:
Опухоли головы и шеи, Vol 6, Iss 1, Pp 13-27 (2016)
This rare tumor from a group of neuroendocrine neoplasms was studied. The material for the study was the data of 78 patients with esthesioneuroblastoma who had been treated and followed up at the N.N. Blokhin Russian Cancer Research Center in the per
Externí odkaz:
https://doaj.org/article/5132b2b51dfe464ba8c6543bd9dfd84e
Autor:
Yu. A. Barsukov, S. I. Tkachev, N. F. Orel, V. A. Aliyev, S. S. Gordeev, V. V. Glebovskaya, Yu. M. Timofeev, A. O. Atroshchenko, A. I. Ovchinnikova, A. V. Nalbandyan
Publikováno v:
Тазовая хирургия и онкология, Vol 5, Iss 1, Pp 54-58 (2015)
Long-term results of conservative squamous-cell rectal cancer treatment (12 cm above anal verge) are presented in the article. Squamous-cell rectal cancer is a rare disease with only 73 cases described in the literature. Patient received a novel chem
Externí odkaz:
https://doaj.org/article/8e5f4ce2d8544f01b85609d5bda480a4
Autor:
V. V. Breder, V. A. Gorbunova, N. F. Orel, K. V. Orlova, A. E. Kuzminov, T. A. Борисова, Yu. V. Bisovskaya, I. N. Gagarin, N. N. Mazurenko, V. V. Mochalnikova, E. N. Kholyavka
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 1, Pp 43-53 (2015)
The review literature regarding endovascular interventions for rectal cancer treatment is presented. The results of treatment of loco-regional rectal carcinoma by with the help of endovascular selective lipiodol oil chemoembolization of the rectal ar
Externí odkaz:
https://doaj.org/article/ea4e203c7f9b41479b951f16c44f0a49
Autor:
A A Kolomeytseva, G S Yemelyanova, V A Gorbunova, N F Orel, N I Perevodchikova, V Yu Bokhyan, A A Fedenko
Publikováno v:
Современная онкология, Vol 19, Iss 3, Pp 42-45 (2017)
A combination of etoposide, doxorubicin and cisplatin plus mitotane (EPD-M) is the most effective regimen in patients with advanced adrenocortical carcinoma (ACC). Because in the Russian Federation mitotane is not registered, there are no publication
Externí odkaz:
https://doaj.org/article/7cfb933f4c51434d80c9bc3275c99fa1
Publikováno v:
Современная онкология, Vol 19, Iss 2, Pp 61-65 (2017)
It is still unknown whether the combination of IFN-α with octreotide has benefit compared with IFN-α alone. We compared efficacy and toxicyty of IFN-α and IFN-α plus octreotide in first line of therapy of patients with NETs. There was trend to lo
Externí odkaz:
https://doaj.org/article/48ae2c23b4b64722ba9e6208d0a0cb34
Autor:
G S Emelyanova, A E Kuzminov, N F Orel, A S Odintsova, A A Markovich, A A Kuznetsova, V A Gorbunova
Publikováno v:
Современная онкология, Vol 18, Iss 1, Pp 80-83 (2016)
Somatostatin analogs plays a key role in the treatment of disseminated well-differentiated functioning and nonfunctioning neuroendocrine tumors (NET). Its ingibit hormonal activity of NET by binding to somatostatin receptors, have antiproliferative e
Externí odkaz:
https://doaj.org/article/096f4df874c740de8cb54cfedc777cfe